In the EU, TEZ/IVA (Symkevi®) is used in patients with CF homozygous for the F508del variant or heterozygous for the F508del and “residual function” CFTR-variant and aged 6 years and older [13,14]. The gene discussed is CFTR; the disease is cystic fibrosis.